Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients.
Kato M, Kawaguchi K, Nakai S, Murakami K, Hori H, Ohashi A, Hiki Y, Ito S, Shimano Y, Suzuki N, Sugiyama S, Ogawa H, Kusimoto H, Mutoh T, Yuzawa Y, Kitaguchi N. Kato M, et al. Among authors: hiki y. J Neural Transm (Vienna). 2012 Dec;119(12):1533-44. doi: 10.1007/s00702-012-0844-5. Epub 2012 Jun 15. J Neural Transm (Vienna). 2012. PMID: 22699459
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.
Kitaguchi N, Hasegawa M, Ito S, Kawaguchi K, Hiki Y, Nakai S, Suzuki N, Shimano Y, Ishida O, Kushimoto H, Kato M, Koide S, Kanayama K, Kato T, Ito K, Takahashi H, Mutoh T, Sugiyama S, Yuzawa Y. Kitaguchi N, et al. Among authors: hiki y. J Neural Transm (Vienna). 2015 Nov;122(11):1593-607. doi: 10.1007/s00702-015-1431-3. Epub 2015 Jul 31. J Neural Transm (Vienna). 2015. PMID: 26228626
Toward the treatment for Alzheimer's disease: adsorption is primary mechanism of removing amyloid β protein with hollow-fiber dialyzers of the suitable materials, polysulfone and polymethyl methacrylate.
Kawaguchi K, Saigusa A, Yamada S, Gotoh T, Nakai S, Hiki Y, Hasegawa M, Yuzawa Y, Kitaguchi N. Kawaguchi K, et al. Among authors: hiki y. J Artif Organs. 2016 Jun;19(2):149-58. doi: 10.1007/s10047-015-0878-1. Epub 2015 Dec 19. J Artif Organs. 2016. PMID: 26686230
Influx of Tau and Amyloid-β Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-β Removal System for Alzheimer's Disease.
Kitaguchi N, Tatebe H, Sakai K, Kawaguchi K, Matsunaga S, Kitajima T, Tomizawa H, Kato M, Sugiyama S, Suzuki N, Mizuno M, Takechi H, Nakai S, Hiki Y, Kushimoto H, Hasegawa M, Yuzawa Y, Tokuda T. Kitaguchi N, et al. Among authors: hiki y. J Alzheimers Dis. 2019;69(3):687-707. doi: 10.3233/JAD-190087. J Alzheimers Dis. 2019. PMID: 31156161
Serum levels of 5-s-cysteinyldopa are correlated with skin colors in hemodialysis patients but not in peritoneal dialysis patients.
Murakami K, Nakanishi Y, Wakamatsu K, Yamamoto K, Kohriyama N, Hasegawa M, Tomita M, Nabeshima K, Hiki Y, Asano S, Kawashima S, Ito Y, Fujita Y, Asada H, Nakai S, Sugiyama S, Ito S. Murakami K, et al. Among authors: hiki y. Blood Purif. 2009;28(3):209-15. doi: 10.1159/000230812. Epub 2009 Jul 31. Blood Purif. 2009. PMID: 19648740
Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy.
Yamamoto Y, Hiki Y, Nakai S, Yamamoto K, Takahashi K, Koide S, Murakami K, Tomita M, Hasegawa M, Kawashima S, Sugiyama S, Yuzawa Y. Yamamoto Y, et al. Among authors: hiki y. Clin Exp Nephrol. 2013 Apr;17(2):218-24. doi: 10.1007/s10157-012-0679-2. Epub 2012 Aug 29. Clin Exp Nephrol. 2013. PMID: 22926695 Free PMC article.
199 results